Biomarkers predicting recurrence and progression of ductal carcinoma in situ treated by lumpectomy alone.
Allred
D Craig
DC
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000175:diagnosis / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000737:chemistry* / Q000175:diagnosis / Q000601:surgery; D019941:Cyclin-Dependent Kinase Inhibitor p16; D051546:Cyclooxygenase 2 / Q000032:analysis; D018450:Disease Progression; D005260:Female; D006801:Humans; D015994:Incidence; D019394:Ki-67 Antigen / Q000032:analysis; D015412:Mastectomy, Segmental; D009363:Neoplasm Proteins / Q000032:analysis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D010173:Palpation; D011237:Predictive Value of Tests; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis
D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16; D051546:Cyclooxygenase 2; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; C000614131:CDKN2A protein, human; C508053:ERBB2 protein, human